HomeOSE • EPA
add
Ose Immunotherapeutics SA
Previous close
€3.68
Day range
€3.62 - €3.75
Year range
€3.62 - €7.70
Market cap
83.11M EUR
Avg Volume
100.01K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 431.00K | — |
Operating expense | 10.22M | — |
Net income | -9.86M | — |
Net profit margin | -2.29K | — |
Earnings per share | — | — |
EBITDA | -9.74M | — |
Effective tax rate | 5.52% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.12M | — |
Total assets | 123.96M | — |
Total liabilities | 60.15M | — |
Total equity | 63.81M | — |
Shares outstanding | 22.31M | — |
Price to book | 1.26 | — |
Return on assets | -19.75% | — |
Return on capital | -22.27% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.86M | — |
Cash from operations | -8.98M | — |
Cash from investing | 4.00M | — |
Cash from financing | 419.50K | — |
Net change in cash | -4.56M | — |
Free cash flow | -4.95M | — |
About
Founded
Nov 17, 2004
Website
Employees
68
